New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 6, 2014
06:46 EDTMNK, CI, QCORPiper does not see heightened risk around Questcor buyout
Piper Jaffray believes Cigna's (CI) coverage policy update regarding Questcor's (QCOR) Acthar Gel is unlikely to have meaningful impact. Piper does not see heightened risk around the closing of Mallinckrodt's (MNK) acquisition of Questcor. Piper says that while Cigna's new language is suggestive of tighter restriction on patient access, there is no "blanket statement that denies coverage beyond the infantile spasms setting." Piper reiterates an Overweight rating on Mallinckrodt with a $90 price target.
News For MNK;QCOR;CI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
August 14, 2015
17:08 EDTMNKPaulson & Co gives quarterly update on stakes
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use